Reduced Appetite and Food Cravings Semaglutide's ability to reduce hunger corresponds to its efficacy as a weight-reduction medication
However, the absence of reported interactions does not constitute proof of safety in all contexts, especially for individuals with hepatic impairment, renal disease, or concurrent medications that affect glucose metabolism
Adverse events were similar between groupsnausea, diarrhea, and constipation occurred at comparable rates, suggesting sermorelin doesn't compound GLP-1-related GI side effects
Be skeptical
Beyond weight reduction, semaglutide has a commendable impact on various health metrics crucial to conditions such as heart disease, stroke, and type 2 diabetes, offering a holistic health improvement approach